Forgot Password

Thank you for your request!

We will soon reach out to you.

Thank you for downloading..!

Contact us for more information.
Home » Healthcare » Medical Devices » HME-3731016

  • Global Pediatric Interventional Cardiology Market Insights, Opportunity Analysis, Market Shares and Forecast, 2017 – 2023

  • Publish: October 2016 | Report Code: HME-3731016

* For discount/customization and buying a particular chapter click here or write to us at [email protected]

Global pediatric interventional cardiology market is expected to have a CAGR of 9% during the forecast period 2016-2023. Interventional cardiology incorporates catheter based treatments for cardiac disease and is performed by specialized interventional cardiologists. Majority of the interventional cardiology process are considered to be simply invasive as they do not engage the use of many tools to go into the body or open surgeries. These actions engage the use of catheters inserted into femoral artery in the upper leg. Real time x-ray is used to direct the catheter towards heart or vascular area. There are numerous benefits of interventional cardiology processes such as little postoperative recovery low threat of infectivity, times and evasion of big scars. The pediatric interventional cardiology market is projected to observer a productive growth in the future years, due to the constant growth of new minimally invasive devices and the increasing population base of pediatric patients. Key factors expected to drive the market demand are:

  • The increasing incidents of inherited heart situations among pediatric patients
  • Initiatives taken by regulatory authorities to strengthen the interventional cardiology division
  • Mounting expenditure for the research and development of new heart valve products




The factors influencing the enhancement of the market are constant advancement in technology coupled with high level of acceptance of superior technologies. In addition, increasing inclination for minimally invasive procedures, augmented investments in R&D by the market players towards development of innovative devices and increased affordability of patients further contributes to the growth of the market. Complex nature of pediatric clinical trials and different regulatory policies delaying the product launches are the constraints for the market. Rising economies and demographics in the emergent countries such as China and India are likely to propose higher opportunities for the global pediatric interventional cardiology market. Additionally, increasing awareness and advancement of some new products with better effectiveness are projected to provide good opportunity for global pediatric interventional cardiology devices market. High costs involved is one of the main challenges faced by global pediatric interventional cardiology devices market.

Source: OBRC Analysis

Global pediatric interventional cardiology market is segmented on the basis of products and imaging techniques. On the basis of products, the market is segmented into:

  • Closure Devices
  • Transcatheter Heart Valves
  • Atherectomy Devices
  • Catheters
  • Guidewires
  • Balloons
  • Stents
  • Other Products









On the basis of imaging techniques, the market is segmented into:

  • Optical Coherence Tomography (OCT) Imaging
  • Intravascular Ultrasound (IVUS)
  • Near Infrared Spectroscopy (NIRS)
  • Other





Due to the fact that cardiac surgeries use transcatheter pulmonary valves have exhibited superior effectiveness, it is estimated that they will fuel the expansion of this market at a steady rate throughout the forecast period. The ASD closure device finds larger application in successfully finishing congenital holes on the walls of the heart. Because of the increasing incidences of congenital cardiac structural defects, it is projected that the heart deficiency closure devices division will see an extensive demand growth in demand future years.

The revenue for the above products and closure devices and imaging techniques segments are specific to the global pediatric interventional cardiology market. However, the total revenue of these products, devices and imaging techniques in general has been excluded from the scope of the report. Also, the total market revenue has been calculated by summing up products, devices and imaging technique segment.

Geographically, the global pediatric interventional cardiology market has been segmented on the basis of four major region, which include:

  • North America (U.S. & Canada)
  • Asia Pacific (China, India, Japan, RoAPAC)
  • Europe (UK, France, Germany, RoE)
  • Rest of World





North America accounted for the largest share in 2016. The continuing research and development programs, development of novel heart valves using decellularized matrices are projected to diminish post-surgery refusal rates and as a result it will contribute tothe market growth in the region. These developments combined with FDA initiatives to reinforce the interventional cardiology regulatory structure are projected to drive the North America pediatric interventional cardiology market in the future years. Asia Pacific is projected to develop at a significant rate during the next seven years due to the growing government funding and support in cardiology and growth of medical tourism.

Key players in the pediatric interventional cardiology market include

  • ABBOTT VASCULAR
  • BOSTON SCIENTIFIC CORPORATION
  • EDWARDS LIFE SCIENCE
  • GE HEALTHCARE
  • MEDTRONIC
  • SIEMENS Healthcare







Detailed analysis of these companies provided in this report comprises of overview, SCOT analysis, product portfolio, strategic initiative and strategic analysis.

The market is extremely oligopolistic, consolidated and aggressive. The market is capital concentrated and demands high investments in research and development programs. Players in the market adopted many strategies such as technical collaboration, partnership agreement, product development and merger& acquisition to capture high market share. In a strategic move on August 2016, Edwards Lifesciences Corporation the worldwide leader in the science of heart valves and hemodynamic monitoring completed its acquisition of CardiAQ Valve Technologies, Inc., a privately held company and manufacturer of a transcatheter mitral valve replacement system.  Joint knowledge and work of the talented CardiAQ and Fortis transcatheter mitral valve system teams will help us advance a therapy that provides a significant solution for patients.

Why to buy the report:

This report will:

  • Provide you the business strategies adopted by market player such as on August 2016, Edwards Lifesciences Corporation acquired CardiAQ Valve Technologies Inc. 
  • Provide in detail the different segments such as products and imaging technique which affect the global pediatric interventional cardiology market.
  • Provide you the patent analysis of global pediatric interventional cardiology market.
  • Identify and understand the strengths, opportunities, challenges and threats of global pediatric interventional cardiology market.
  • Provide revenues of major players of the market such as GE Healthcare, Siemens Healthcare and Medtronic Inc.
  • Provide you various regulatory policies which affect the global pediatric interventional cardiology market.







How we are different from others:

At Occams we provide an extensive portfolio which is comprehensive market analysis along with the market size, market share, and market segmentations. Our report on global pediatric interventional cardiology market offers the longest chain of market segmentation covering major market segmentation based on products, closure devices and imaging techniques. The report tracks the major market trends in the global Pediatric interventional cardiology market such as rising population base of pediatric patients and continuous development for minimally invasive devices.   For each market segments covered in global pediatric interventional cardiology market report, we provide opportunity matrix, and DROC analysis, that enable the clear growth assessment across each market segment. The report discusses competitive landscape of the pediatric interventional cardiology industry, with giving extensive strategy analysis of more than 15 companies. Moreover, the report discusses various models such as 360-degree analysis, See Saw analysis, and Porter five force model and so on. For the high-level analysis in the report we provide a comparative analysis of historic and current year data. 

Key findings of the global pediatric interventional cardiology market:

  • The rising incidents of inherited heart situation among pediatric patientsfueling growth in global pediatric interventional cardiology market.
  • North America had the largest revenue share in 2016.
  • ASD (ArtialSeptal Defect), PFO (Patent Foreman Ovale) and VSD (VentricalSeptal Defect) based on closure device segment is the dominating market due to rising demand for these devices.
  • Product launch is the key strategy adopted by the various market players of global pediatric interventional cardiology market.
1. INTRODUCTION
1.1. EXECUTIVE SUMMARY
1.2. ESTIMATION METHODOLOGY
 
2. MARKET OVERVIEW
2.1. GLOBAL  PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET: EVOLUTION & TRANSITION
2.2. MARKET DEFINITION AND SCOPE
2.3. INDUSTRY STRUCTURE
2.4. REGULATORY FRAMEWORK
2.5. TOTAL MARKET ANALYSIS
2.5.1. TOP 5 FINDINGS
2.5.2. TOP 5 OPPORTUNITY MARKETS
2.5.3. TOP 5 COMPANIES
2.5.4. TOP 3 COMPETITIVE STRATEGIES
2.6. ESTIMATION ANALYSIS
2.7. STRATEGIC ANALYSIS
2.7.1. INVESTMENT VS. ADOPTION MODEL
2.7.2. 360 DEGREE INDUSTRY ANALYSIS
2.7.3. PORTERS 5 FORCE MODEL
2.7.4. SEE-SAW ANALYSIS
2.7.5. PRICING ANALYSIS
2.7.6. CONSUMER ANALYSIS AND KEY BUYING CRITERIA
2.8. COMPETITIVE ANALYSIS
2.8.1. KEY STRATEGIES AND ANALYSIS
2.8.2. MARKET SHARE&TOP COMPANY ANALYSIS
2.9. STRATEGIC RECOMMENDATIONS & KEY CONCLUSIONS
2.9.1. INVESTMENT OPPORTUNITIES BY REGIONS
2.9.2. OPPORTUNITIES IN EMERGING APPLICATIONS
2.9.3. INVESTMENT OPPORTUNITY IN FASTEST GROWING SEGMENT
 
3. MARKET DETERMINANTS 
3.1. MARKET DRIVERS
3.1.1. RAPID TECHNOLOGICAL ADVANCES TO BOOST THE MARKET GROWTH
3.1.2. INCREASED PREFERENCE OF MINIMALLY INVASIVE PROCEDURE OVER CANVENTIONAL SURGERIES
3.1.3. RISING GOVERNMENT SUPPORT TOWARDS  PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET
3.1.4. RISING AWARENESS AMONG THE POPULATION 
3.2. MARKET RESTRAINTS
3.2.1. DIFFERENT REGULATORY POLICIES DELAYING THE PRODUCT LAUNCHES 
3.2.2. UNFAVORABLE MARKET CONDITIONS FOR NEW PLAYERS
3.2.3. COMPLEX NATURE OF PEDIATRIC CLINICAL TRIALS 
3.3. MARKET OPPORTUNITIES
3.3.1. ADVANCES IN BIODEGRADABLE DEVICES FOR PEDIATRIC CARDIOLOGY 
3.3.2. ASIA-PACIFIC REGION PRESENTS SIGNIFICANT GROWTH OPPORTUNITIES 
3.3.3. MOBILE CATH LABS, AN UPCOMING OPPORTUNITY AREA
3.3.4. REBUST GROWTH IN THE TRANSCATHETER HEART VALVES MARKET 
3.3.5. EXPECTED HIGH DEMAND GROWTH IN ASIA’S HEALTHCARE INDUSTRY 
3.4.  MARKET CHALLENGES 
3.4.1. DIFICULTIES IN PEDIATRIC CLINICAL TRIALS 
3.4.2. HIGH COST OF PEDIATRIC INTERVENTIONAL CARDIOLOGY IMAGING DEVICES 
 
4. MARKET SEGMENTATION 
4.1. GLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY  MARKET BYPRODUCT 
4.1.1. MARKET DEFINITION AND SCOPE
4.1.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.1.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.1.4. OPPORTUNITY MATRIX
4.1.5. MARKET SEGMENTATION 
4.1.5.1. GLOBAL CLOSURE DEVICES  MARKET 
4.1.5.1.1. APPLICATIONS
4.1.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.1.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.1.5. KEY CONCLUSIONS
4.1.5.2. GLOBAL TRANSCATHETER HEART VALVES  MARKET 
4.1.5.2.1. APPLICATIONS
4.1.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.2.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.2.5. KEY CONCLUSIONS
4.1.5.3. GLOBAL ATHERCTOMY DEVICES  MARKET 
4.1.5.3.1. APPLICATIONS
4.1.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.3.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.3.5. KEY CONCLUSIONS
4.1.5.4. GLOBAL CATHETERS MARKET
4.1.5.4.1. APPLICATIONS
4.1.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.4.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.4.5. KEY CONCLUSIONS
4.1.5.5. GLOBAL GUIDEWIRES  MARKET
4.1.5.5.1. APPLICATIONS
4.1.5.5.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.5.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.5.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.5.5. KEY CONCLUSIONS
4.1.5.6. GLOBAL BALLON  MARKET 
4.1.5.6.1. APPLICATIONS
4.1.5.6.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.6.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.6.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.6.5. KEY CONCLUSIONS
4.1.5.7. GLOBAL STENTS  MARKET 
4.1.5.7.1. APPLICATIONS
4.1.5.7.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.7.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.7.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.7.5. KEY CONCLUSIONS
4.1.5.8. GLOBAL  OTHER PRODUCTS MARKET 
4.1.5.8.1. APPLICATIONS
4.1.5.8.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.1.5.8.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.1.5.8.4. KEY PLAYERS & KEY PRODUCTS
4.1.5.8.5. KEY CONCLUSIONS
4.2. KEY PLAYERS & KEY PRODUCTSKEY PLAYERS & KEY PRODUCTSKEY PLAYERS & KEY PRODUCTSKEY PLAYERS & KEY PRODUCTSGLOBAL PEDIATRIC INTERVENTIONAL CARDIOLOGY  MARKET BY IMAGING TECHNIQUE 
4.2.1. MARKET DEFINITION AND SCOPE
4.2.2. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
4.2.3. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
4.2.4. OPPORTUNITY MATRIX
4.2.5. MARKET SEGMENTATION 
4.2.5.1. GLOBAL OPTICAL COHERENCE TOMOGRAPHY (OCT) IMAGING MARKET 
4.2.5.1.1. APPLICATIONS
4.2.5.1.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.1.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.1.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.1.5. KEY CONCLUSIONS
4.2.5.2. GLOBAL INTRAVASCULAR  ULTRASOUND(IVUS) MARKET 
4.2.5.2.1. APPLICATIONS
4.2.5.2.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.2.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.2.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.2.5. KEY CONCLUSIONS
4.2.5.3. GLOBAL  NEAR INFRARED SPECTROSCOPY(NIRS)MARKET 
4.2.5.3.1. APPLICATIONS
4.2.5.3.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.3.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.3.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.3.5. KEY CONCLUSIONS
4.2.5.4. GLOBAL  OTHER IMAGING TECHNIQUES  MARKET 
4.2.5.4.1. APPLICATIONS
4.2.5.4.2. ADOPTION SCENARIO & MARKET DETERMINANTS
4.2.5.4.3. MARKET ESTIMATIONS AND FORECASTS 2014-2023 ($ MILLION)
4.2.5.4.4. KEY PLAYERS & KEY PRODUCTS
4.2.5.4.5. KEY CONCLUSION
 
5. COMPETITIVE LANDSCAPE
5.1. KEY STRATEGIES
5.1.1. LIST OF MERGERS & ACQUISITION 
5.1.2. LIST OF JOINT VENTURES
5.1.3. LIST OF PRODUCT LAUNCHES
5.1.4. LIST OF PARTNERSHIPS
 
6. GLOBAL  PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET BY REGION 
6.1. DECISION SUPPORT DATABASE & ESTIMATION METHODOLOGY
6.2. COMPARATIVE ANALYSIS ACROSS MARKET SEGMENTS
6.3. OPPORTUNITY MATRIX
6.4. GEOGRAPHIC SEGMENTATION
6.4.1. NORTH AMERICA
6.4.1.1. INDUSTRY APPLICATION ANALYSIS
6.4.1.2. TOP COUNTRY ANALYSIS
6.4.1.2.1. U.S. 
6.4.1.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023($MILLION)
6.4.1.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.1.3. KEY CONCLUSIONS
6.4.1.2.2. CANADA
6.4.1.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.1.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.1.2.2.3. KEY CONCLUSIONS
6.4.2. EUROPE
6.4.2.1. INDUSTRY APPLICATION ANALYSIS
6.4.2.2. TOP COUNTRY ANALYSIS
6.4.2.2.1. UK
6.4.2.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.1.3. KEY CONCLUSIONS
6.4.2.2.2. FRANCE
6.4.2.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.2.3. KEY CONCLUSIONS
6.4.2.2.3. GERMANY
6.4.2.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.3.3. KEY CONCLUSIONS
6.4.2.2.4. SPAIN
6.4.2.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.4.3. KEY CONCLUSIONS
6.4.2.2.5. ITALY 
6.4.2.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.5.3. KEY CONCLUSIONS
6.4.2.2.6. REST OF EUROPE
6.4.2.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.2.2.6.2. KEY PLAYERS & KEY PRODUCTS
6.4.2.2.6.3. KEY CONCLUSIONS
6.4.3. ASIA PACIFIC
6.4.3.1. INDUSTRY APPLICATION ANALYSIS
6.4.3.2. TOP COUNTRY ANALYSIS
6.4.3.2.1. CHINA
6.4.3.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.1.3. KEY CONCLUSIONS
6.4.3.2.2. INDIA
6.4.3.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.2.3. KEY CONCLUSIONS
6.4.3.2.3. JAPAN
6.4.3.2.3.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.3.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.3.3. KEY CONCLUSIONS
6.4.3.2.4. SOUTH KOREA
6.4.3.2.4.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.4.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.4.3. KEY CONCLUSIONS
6.4.3.2.5. AUSTRALIA
6.4.3.2.5.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.5.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.5.3. KEY CONCLUSIONS
6.4.3.2.6. REST OF ASIA PACIFIC
6.4.3.2.6.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.3.2.6.2. KEY PLAYERS & KEY PRODUCTS
6.4.3.2.6.3. KEY CONCLUSIONS
6.4.4. ROW
6.4.4.1. INDUSTRY APPLICATION ANALYSIS
6.4.4.2. TOP COUNTRY ANALYSIS
6.4.4.2.1. LATIN AMERICA
6.4.4.2.1.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.4.2.1.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.1.3. KEY CONCLUSIONS
6.4.4.2.2. MIDDLE EAST & AFRICA 
6.4.4.2.2.1. MARKET ESTIMATIONS AND FORECASTS 2014-2023
6.4.4.2.2.2. KEY PLAYERS & KEY PRODUCTS
6.4.4.2.2.3. KEY CONCLUSIONS
 
7. COMPANY PROFILES
7.1. ABBOTT VASCULAR 
7.1.1. OVERVIEW
7.1.2. PRODUCT PORTFOLIO
7.1.3. STRATEGIC INITIATIVES 
7.1.4. SCOT ANALYSIS
7.2. BOSTON SCIENTIFIC CORPORATION 
7.2.1. OVERVIEW
7.2.2. PRODUCT PORTFOLIO
7.2.3. STRATEGIC INITIATIVES 
7.2.4. SCOT ANALYSIS 
7.3. CORDIS 
7.3.1. OVERVIEW
7.3.2. PRODUCT PORTFOLIO
7.3.3. STRATEGIC INITIATIVES 
7.3.4. SCOT ANALYSIS
7.4. EDWARDS LIFE SCIENCE
7.4.1. OVERVIEW
7.4.2. PRODUCT PORTFOLIO
7.4.3. STRATEGIC INITIATIVES 
7.4.4. SCOT ANALYSIS
7.5. GE HEALTHCARE 
7.5.1. OVERVIEW
7.5.2. PRODUCT PORTFOLIO
7.5.3. STRATEGIC INITIATIVES 
7.5.4. SCOT ANALYSIS
7.6. GETINGE 
7.6.1. OVERVIEW
7.6.2. PRODUCT PORTFOLIO
7.6.3. STRATEGIC INITIATIVES 
7.6.4. SCOT ANALYSIS 
7.7. GORE MEDICAL
7.7.1. OVERVIEW
7.7.2. PRODUCT PORTFOLIO
7.7.3. STRATEGIC INITIATIVES 
7.7.4. SCOT ANALYSIS 
7.8. JOHNSON & JOHNSON
7.8.1. OVERVIEW
7.8.2. PRODUCT PORTFOLIO
7.8.3. STRATEGIC INITIATIVES 
7.8.4. SCOT ANALYSIS 
7.9. LEPU MEDICAL TECHNOLOGY 
7.9.1. OVERVIEW
7.9.2. PRODUCT PORTFOLIO
7.9.3. STRATEGIC INITIATIVES 
7.9.4. SCOT ANALYSIS 
7.10. MEDTRONIC 
7.10.1. OVERVIEW
7.10.2. PRODUCT PORTFOLIO
7.10.3. STRATEGIC INITIATIVES 
7.10.4. SCOT ANALYSIS
7.11. NUMED
7.11.1. OVERVIEW
7.11.2. PRODUCT PORTFOLIO
7.11.3. STRATEGIC INITIATIVES 
7.11.4. SCOT ANALYSIS 
7.12. SIEMENS HEALTHCARE 
7.12.1. OVERVIEW
7.12.2. PRODUCT PORTFOLIO
7.12.3. STRATEGIC INITIATIVES 
7.12.4. SCOT ANALYSIS 
7.13. TOSHIBA 
7.13.1. OVERVIEW
7.13.2. PRODUCT PORTFOLIO
7.13.3. STRATEGIC INITIATIVES 
7.13.4. SCOT ANALYSIS
7.14. ST. JUDE MEDICAL
7.14.1. OVERVIEW
7.14.2. PRODUCT PORTFOLIO
7.14.3. STRATEGIC INITIATIVES 
7.14.4. SCOT ANALYSIS 
7.15. TERUMO
7.15.1. OVERVIEW
7.15.2. PRODUCT PORTFOLIO
7.15.3. STRATEGIC INITIATIVES 
7.15.4. SCOT ANALYSIS
 
LIST OF TABLES
 
1. GLOBL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET BY PRODUCT 2014-2023($ MILLION)
2. GLOBAL CLOSURE DEVICES  BY  GEOGRAPHY 2014-2023($ MILLION)
3. GLOBAL TRANSCATHETER HEART VALVES BY  GEOGRAPHY 2014-2023($ MILLION)
4. GLOBAL ATHERECTOMY DEVICES  BY  GEOGRAPHY 2014-2023($ MILLION)
5. GLOBALCATHETERS  BY  GEOGRAPHY 2014-2023($ MILLION)
6. GLOBAL GUIDEWIRES  BY  GEOGRAPHY 2014-2023($ MILLION)
7. GLOBAL BALLONS  BY GEOGRAPHY 2014-2023($MILLION)
8. GLOBAL STENTS   BY GEOGRAPHY 2014-2023($MILLION)
9. GLOBAL OTHER PRODUCTS   BY GEOGRAPHY 2014-2023($MILLION)
10. GLOBL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET BY CLOSURE DEVICES2014-2023($ MILLION)
11. GLOBL PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET BY IMAGING TECNIQUE2014-2023($ MILLION)
12. GLOBAL  OPTICAL COHERENCE TOMOGRAPHY(OCT) IMAGING  BY GEOGRAPHY 2014-2023($ MILLION)
13. GLOBAL  INTRAVASCULAR ULTRASOUND(IVUS) BY GEOGRAPHY 2014-2023($ MILLION)
14. GLOBAL  NEAR INFRARED SPECTROSCOPY(NIRS) BY GEOGRAPHY 2014-2023($ MILLION)
15. GLOBAL OTHER  IMAGING TECHNIQUES  BY GEOGRAPHY 2014-2023($ MILLION)
 
LIST OF FIGURES
 
1. GLOBAL  PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET BY CLOSURE DEVICES 2014-2023($ MILLION)
2. GLOBAL  PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET BY TRANSCATHETER HEART VALVES 2014-2023 ($ MILLION)
3. GLOBAL  PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET BY ATHERECTOMY DEVICES 2014-2023 ($ MILLION)
4. GLOBAL  PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET BY  CATHETERS 2014-2023 ($ MILLION)
5. GLOBAL  PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET BY  GUIDEWIRES 2014-2023 ($ MILLION)
6. GLOBAL  PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET BY BALLONS 2014-2023 ($ MILLION)
7. GLOBAL  PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET BY STENTS 2014-2023 ($ MILLION)
8. GLOBAL  PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET BY OTHER PRODUCTS 2014-2023 ($ MILLION)
9. GLOBAL  PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET BY OPTICAL COHERENCE TOMOGRAPHY(OCT) IMAGING  2014-2023 ($ MILLION)
10. GLOBAL  PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET BY INTRAVASCULAR ULTRASOUND (IVUS) 2014-2023 ($ MILLION)
11. GLOBAL  PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET BY NEAR INFRARED SPECTROSCOPY(NIRS) 2014-2023 ($ MILLION)
12. GLOBAL  PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET BY OTHER IMAGING TECHNIQUES 2014-2023 ($ MILLION)
13. UNITED STATES (U.S.)PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)
14. CANADA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)
15. UNITED KINGDOM (UK) PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)
16. FRANCE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)
17. GERMANY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)
18. SPAIN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET 2014-2023 ($MILLION)
19. ITALY PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)
20. ROE PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)
21. INDIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)
22. CHINA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)
23. JAPAN PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)
24. KOREA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)
25. AUSTRALIA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)
26. ROW APAC PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)
27. LATIN AMERICA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)
28. MENA PEDIATRIC INTERVENTIONAL CARDIOLOGY MARKET 2014-2023 ($ MILLION)

FAQ

How can I purchase a report?
We offer an easy way to purchase any report of your choice from various domains that we offer. You can easily search for your desired reports by simply using the search bar on our website's home page. For multiple purchases, you can add reports to the shopping cart, fill a detail form and check out. We accept payments though authentic and trusted payment gateways which accept all major credit cards.
How safe is to use my credit card? Is my information secure?
We ensure complete safety to all online transactions made by credit cards. We use most secure encryption technology available today for the electronic transactions and all our credit card sales are secured with an SSL technology. Your information is highly secure and confidential.
Can I get a discount?
We send discount offers through email as per your request. In case you would like to receive discounts, please sign up for our newsletter.
I want to buy only a chapter. I don't need complete report.
Yes you can buy your desired chapter/page or the entire report, by just clicking on the table of contents in any report and selecting chapter of your interest. We do have separate pricing for chapters/reports/excel sheets/presentation pages etc.
Can I get reports on my desired topic specially which is not available in your current portfolio?
Do call us or mail us the topic of your preference. Our dedicated team on analysts will prepare a report as per your preference and requirements.
When do I get access to the report(s) that I have purchased?
We will email you your purchased report right after we receive your payment through any of the payment options.
Will I receive any invoice for my purchase?
Yes we will email you invoice/payment confirmation with the order details once we receive your payment.
In what format will the reports be available in?
All the reports will be available in PDF format for download.

Request for Sample
Select License Type
Required More Information

0731 4042636

+91 8390547755

NAVIGATION LINK

OUR SERVICES

credit card

CONNECT WITH US

Occams Business Research & Consulting Pvt. Ltd.

Landline: 0731 4042636 

Handheld: +91 8390547755

Email: [email protected]

 

 

  • facebook
  • twitter
  • blog
  • linkdin
  • google plus
  • youtube
Go To Top
viewthroughconversion